COMMUNIQUÉS West-GlobeNewswire

-
Akers Biosciences Reports Fiscal Year 2018 Earnings
01/04/2019 -
Hemispherx Reports 2018 Year-end Financial Results
01/04/2019 -
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/04/2019 -
DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
01/04/2019 -
DBV Technologies Publie son Document de Référence 2018 et son « Form 20-F » américain
01/04/2019 -
EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results
01/04/2019 -
Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
01/04/2019 -
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update
01/04/2019 -
Supernus Announces Webcast of Investor Day on April 16, 2019
01/04/2019 -
Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update
01/04/2019 -
Atara Biotherapeutics Presents Off-the-Shelf, Allogeneic CAR T Preclinical Results at the American Association of Cancer Research (AACR) Annual Meeting 2019
01/04/2019 -
AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado
01/04/2019 -
BeiGene Announces Phase 1 Long-Term Exposure Data and Results from Structural and Mechanistic Analyses on Tislelizumab at the AACR Annual Meeting
01/04/2019 -
Wright Medical Group N.V. to Present at Needham Healthcare Conference
01/04/2019 -
Precision BioSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
01/04/2019 -
Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Aaron Osborne, MBBS MRCOphth, as Chief Medical Officer
01/04/2019 -
Align Technology to Announce First Quarter 2019 Results on April 24, 2019
01/04/2019 -
Nkarta Therapeutics Presents Data at AACR Demonstrating Proprietary NK Cell Engineering and Expansion Technology Enhances Potency and Cytotoxicity of NK Cells
01/04/2019 -
Cytokinetics to Present at April Investor Conferences
01/04/2019
Pages